2024-10-23 02:53:12
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria
Health/ 2023-07-22
Yiling Pharmaceutical: Lianhua Qingwen A...

SHIJIAZHUANG,China,May 12,2022--Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qi...

Dizal Announces New Data from the Phase I/II Study of Golidocitnib in Refractory or Relapsed Peripheral T Cell Lymphoma Selected for Oral Presentation at 2022 EHA Annual Meeting
Corporate/ 2023-07-24
Dizal Announces New Data from the Phase ...

SHANGHAI,May 13,2022--Dizal (SSE: 688192) will present the data from an ongoing phase I/II study of golidocitnib,a selective JAK1 inhibitor,...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release